Single User License
INR 11904
Site License
INR 23807
Corporate User License
INR 35711

Service Tax Additional

select a format
Price

Single User License
USD 175
Site License
USD 350
Corporate User License
USD 525

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Rigel Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Rigel Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report


  Request for Sample Report

Executive Summary

Rigel Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis

An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Rigel Pharmaceuticals, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier

Support sales activities by understanding your customers' businesses better

Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects

Key Highlights

Rigel Pharmaceuticals (Rigel or 'the company') is a clinical-stage drug development company engaged in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune disorders, as well as muscle disorders. The company operates in the US, where it is headquartered in South San Francisco, California. It employed 127 people as of December 31, 2014.

Company Snapshot

Rigel Pharmaceuticals, Inc.: Company Overview

Rigel Pharmaceuticals, Inc.: Overview and Key Facts

Rigel Pharmaceuticals, Inc.: Overview

Rigel Pharmaceuticals, Inc.: Key Facts

Rigel Pharmaceuticals, Inc.: Key Employees

Rigel Pharmaceuticals, Inc.: Key Employee Biographies

Rigel Pharmaceuticals, Inc.: Major Products and Services

Rigel Pharmaceuticals, Inc.: Company History

Rigel Pharmaceuticals, Inc.: Management Statement

Rigel Pharmaceuticals, Inc.: Locations and Subsidiaries

Rigel Pharmaceuticals, Inc.: Key Competitors

Rigel Pharmaceuticals, Inc.: Company Analysis

Rigel Pharmaceuticals, Inc.: Business Description

Rigel Pharmaceuticals, Inc.: SWOT Analysis

Rigel Pharmaceuticals, Inc.: SWOT Overview

Rigel Pharmaceuticals, Inc.: Strengths

Rigel Pharmaceuticals, Inc.: Weaknesses

Rigel Pharmaceuticals, Inc.: Opportunities

Rigel Pharmaceuticals, Inc.: Threats

Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Rigel Pharmaceuticals, Inc.: Financial Deals Overview

Rigel Pharmaceuticals, Inc.: Targets and Partners

Rigel Pharmaceuticals, Inc.: Top Deals 2012-2016YTD*

Rigel Pharmaceuticals, Inc.: Advisors

Rigel Pharmaceuticals, Inc.: Top Financial Advisors

Rigel Pharmaceuticals, Inc.: Capital Raising

Rigel Pharmaceuticals, Inc.: Partnership

Rigel Pharmaceuticals, Inc.: Recent Developments

Rigel Pharmaceuticals, Inc.: News and Events Summary

Rigel Pharmaceuticals, Inc.: Corporate Governance

Rigel Pharmaceuticals, Inc.: Financial Performance

Rigel Pharmaceuticals, Inc.: Research & Development

Appendix

Contact Us

Methodology

Definitions

About Datamonitor

Figure 1: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Figure 3: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2012-YTD*2016)

Figure 4: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2012-YTD*2016)

Figure 5: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2012-YTD*2016)

Figure 6: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2012-YTD*2016)

Table 1: Rigel Pharmaceuticals, Inc.: Key Facts

Table 2: Rigel Pharmaceuticals, Inc.: Key Employees

Table 4: Rigel Pharmaceuticals, Inc.: Key Competitors

Table 5: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Table 7: Rigel Pharmaceuticals, Inc.: Targets and Partners

Table 8: Rigel Pharmaceuticals, Inc.: Top Deals 2012-2016YTD*

Table 9: Rigel Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)

Table 10: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2012-YTD*2016)

Table 11: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2012-YTD*2016)

Table 12: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2012-YTD*2016)

Table 13: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2012-YTD*2016)

Table 14: Rigel Pharmaceuticals, Inc.: News and Events Summary

Table 15: Rigel Pharmaceuticals, Inc.: Corporate Governance

Table 16: Rigel Pharmaceuticals, Inc.: Financial Performance

Table 17: Rigel Pharmaceuticals, Inc.: Research & Development

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Rigel Pharmaceuticals, Inc.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com